Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies.

Polgárová, Kamila; Otáhal, Pavel; Sálek, Cyril; Pytlík, Robert.

Afiliación

Polgárová K; 1st Department of Medicine, First Faculty of Medicine, Charles University, Prague, Czechia.
Otáhal P; 1st Department of Medicine, General University Hospital in Prague, Prague, Czechia.
Sálek C; Department of Immunotherapy, Institute of Haematology and Blood Transfusion, Prague, Czechia.
Pytlík R; Institute of Clinical and Experimental Hematology, First Faculty of Medicine, Charles University, Prague, Czechia.

Front Oncol ; 12: 876758, 2022.

Article en En | MEDLINE | ID: mdl-35600381